The 2026 Priestley Medalist and Nobel laureate struggled with finding her way through school before achieving the greatest feats in science ...

A research team in China says it has removed HIV genetic material from human cells using CRISPR gene-editing technology. The findings are still at the laboratory stage, but they have drawn global ...

A new study from China has sparked global attention after researchers reported that they successfully removed HIV from the DNA of human cells using CRISPR gene-editing technology. The development, ...

CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its its gene-editing therapy's slow rollout. But its development partner, ...

Adoptive T-cell therapy has transformed the treatment landscape of several hematologic malignancies. However, patients living with HIV infection have been largely excluded from this progress.

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand. The ...

Park is a senior health correspondent at TIME. She covers the COVID-19 pandemic, new drug developments in cancer and ...

Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The transformation of HIV ...

HIV’s biggest challenge has been its ability to hide and remain dormant in pockets of healthy immune cells, specifically CD4+ T-cells, making it nearly impossible for drugs or the immune system to ...